Clinical Study of Pregnant Women With COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

54 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-21

Study Completion Date

2021-04-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A new pandemic, COVID-19, has spread rapidly around the world. She does not spare pregnant women. Little is known about the clinical course of pregnant women infected with COVID-19. As of April 1, 2020, six case series and one case report for a total of 61 pregnancies affected by COVID-19, all from the pandemic epicenter in China, except for one state case report -Unis, have been published. These preliminary reports suggest that pregnant women are not more seriously affected than the general population and show a certain gap with what we have observed in the care of pregnant women at HUS. For these reasons, additional information, especially from parts of the world other than China, as the severity of the disease can vary from country to country, is urgently needed to determine whether pregnant women with the disease of COVID-19 will not present with severe pneumonia to COVID-19.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy

NCT04319016

Infection Viral

UNKNOWN

Obstetric and Perinatal Outcomes of Women With COVID-19

NCT04369859

Pregnant Women

COMPLETED

Covid-19 Infection in Pregnancy

NCT04869202

Perinatology

COMPLETED

Exploratory Study: COVID-19 and Pregnancy

NCT04647994

Pregnant Women Covid19

UNKNOWN

Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19

NCT04598347

Covid19 Pregnancy Related

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult woman (≥18 years old)
* Pregnant woman
* Suffering from a confirmed or suspected COVID-19 infection
* Patient who has been medically treated at Strasbourg University Hospitals as well as for his newborn baby, between 03/01/2020 and April 30, 2020
* Woman having given, after information, her agreement for the reuse of her data for the purposes of this research

Exclusion Criteria

* Patient who expressed her opposition to participating in the study
* Patient under guardianship or under guardianship
* Patient under legal protection

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No